TransMedics Group is trading at $79.80, up 4.29%, in pre-market on October 16, 2026; healthcare-sector strength is the clearest available context for the move. - XLV is up 1.45% pre-market, consistent with a sector-led move. - No fresh company announcement surfaced in the search; the investor-relations page lists the August 4, 2026 second-quarter results as its latest release. This does not establish direct causation.